This is a prospective, open label, single center, self-controlled clinical study to demonstrate the safety and efficacy of intradermal botulinum toxin in treating hypertrophic scarring.
Study Type
INTERVENTIONAL
Allocation
NA
Purpose
TREATMENT
Masking
NONE
Enrollment
20
Intradermal injection with Botox 100U/mL will be performed using a 25g needle. Each subject will receive three treatments spaced 1 month apart.
Laser & Skin Surgery Center of New York
New York, New York, United States
RECRUITINGImprovement of hypertrophic scars based on the Subject and Observer Scar Assessment Scale
Time frame: change from baseline at 6 months after treatment
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.